Skip to main content

Table 1 Demographic and intra-operative characteristics

From: Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study

 

Midodrine group

Control group

p value

N

74

74

 

Age

68 [62–75]

65 [58–73.25]

0.184

Male

45 (60.8%)

47 (63.5%)

0.735

Type of surgery

  

0.220

 Revascularization

38 (51.4%)

33 (44.6%)

 

 Valve surgery

17 (23.0%)

19 (25.7%)

 

 Combined

16 (21.6%)

22 (29.7%)

 

 Other

3 (4.1%)

0 (0%)

 

Urgent surgery

15 (20.3%)

10 (13.5%)

0.273

Euroscore II

1.94 [1–2.91]

2.08 [1.31–4.0]

0.088

CPB duration (min)

77 [61–111]

93 [68–120]

0.067

Aortic cross-clamp time (min)

56 [40–82]

69 [40–91]

0.188

PRBC during surgery

0.41 ± 1.33

0.24 ± 0.37

0.21

Fluid balance during surgery (ml)

1037 [318–1850]

951 [595–1605]

0.907

Receiving ACEi or ARB

42 (56.8%)

50 (67.6%)

0.175

  1. ACEi angiotensin conversion enzyme inhibitors, ARB angiotensin receptor blockers, CPB cardiopulmonary bypass, PRBC packed red blood cells